Teva Pharma's Key Branded Drugs Fuel Strong Revenue Growth, Lifts Full-Year Profit Outlook

15 hours ago

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) reported its third-quarter 2025 financial results on Wednesday, with total revenue of $4.48 billion, …

Read Entire Article

Teva Pharma's Key Branded Drugs Fuel Strong Revenue Growth, Lifts Full-Year Profit Outlook

Related

Money-losing Japanese automaker Nissan is selling its headqu...

$72M Equity Investment From Top Firms Bolsters Canaan’s Bitc...

Daiichi Jitsugyo Reports Strong First Half 2025 Financial Re...

DOGE Holds $0.16 Support as Profit-Taking Caps Breakout Atte...

Cracking down on fraud: Using tech to battle counterfeit win...

Issuers update XRP ETF filings to bypass shutdown delays: La...

Bitcoin’s Relief Rally Lifts Spirits: Is it Time to Buy the ...

‘Ethereum is scaling’ — ETH maxis cheer as TPS hits record 2...

Popular

"The Real Reason Trump Loves Crypto" 🏛️⚡ cryptocasey

Bitcoin เด้งเหนือ 100K หลังล้างพอร์ต 2 พันล้าน! กระทิงบอบช้ำ...

🤖How to Prep for AGI Onslaught — Is It Really That Bad? ⚠️

THIS CHANGED EVERYTHING FOR XRP xrp ripple crypto

Gemini Targets Prediction Markets in Bid to Expand Revenue S...

Angle down icon